学术探索
学术期刊
新闻热点
数据分析
智能评审

Randomized trials in melanoma: An update

被引：14
作者：
Eggermont, Alexander M. M. [1 ]
机构：
[1] Dr Daniel Den Hoed Canc Ctr, Erasmus Med Ctr, NL-3075 EA Rotterdam, Netherlands
来源：
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA | 2006年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.soc.2005.12.001
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
No effective therapy for metastatic melanoma exists. Polychemotherapy or chemoimmunotherapy have not shown survival benefits. Vaccines have shown little activity in stage IV disease. To advance the identification of effective agents, new drugs can and should be offered as first-line treatment. Efforts must be made to,improve understanding of the biology of malignant melanoma. Too many phase III trials have been conducted with a poor understanding of the mechanism of action of the involved drugs.
引用
收藏
页码：439 / +
页数：14
相关论文
共 78 条
  • [51] Sentinel lymphonodectomy does not increase the risk of loco-regional cutaneous metastases of malignant melanomas
    Kretschmer, L
    Beckmann, I
    Thoms, KM
    Haenssle, H
    Bertsch, HP
    Neumann, C
    [J]. EUROPEAN JOURNAL OF CANCER, 2005, 41 (04) : 531 - 538
  • [52] Interferon alfa therapy for malignant melanoma: A systematic review of randomized controlled trials
    Lens, MB
    Dawes, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (07) : 1818 - 1825
  • [53] IMPROVED SURVIVAL IN STAGE-III MELANOMA PATIENTS WITH GM2 ANTIBODIES - A RANDOMIZED TRIAL OF ADJUVANT VACCINATION WITH GM2 GANGLIOSIDE
    LIVINGSTON, PO
    WONG, GYC
    ADLURI, S
    TAO, Y
    PADAVAN, M
    PARENTE, R
    HANLON, C
    CALVES, MJ
    HELLING, F
    RITTER, G
    OETTGEN, HF
    LLOYD, JO
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1994, 12 (05) : 1036 - 1044
  • [54] Middleton MR, 2000, BRIT J CANCER, V82, P1158
  • [55] MORTON DL, 1992, ARCH SURG-CHICAGO, V127, P392
  • [56] MORTON DL, 2005, INTERIM RESULTS MULT
  • [57] Low risk of in-transit metastasis in patients with cutaneous melanoma undergoing sentinal lymph node biopsy
    Pawlik, TM
    Ross, MI
    Thompson, JF
    Eggermont, AMM
    Gershenwald, JE
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (21) : 4588 - 4590
  • [58] Cisplatin, dacarbazine with or without subcutaneous interleukin-2, and interferon alfa-2b in advanced melanoma outpatients: Results from an Italian Multicenter phase III Randomized Clinical Trial
    Ridolfi, R
    Chiarion-Sileni, V
    Guido, M
    Romanini, A
    Labianca, R
    Freschi, A
    Lo Re, G
    Nortilli, R
    Brugnara, S
    Vitali, P
    Nanni, O
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) : 1600 - 1607
  • [59] RINGBORG U, 2005, P 6 WORLD C MEL VANC
  • [60] Prospective randomized trial of the treatment of patients with metastatic melanoma using chemotherapy with cisplatin, dacarbazine, and tamoxifen alone or in combination with interleukin-2 and interferon alfa-2b
    Rosenberg, SA
    Yang, JC
    Schwartzentruber, DJ
    Hwu, P
    Marincola, FM
    Topalian, SL
    Seipp, CA
    Einhorn, JH
    White, DE
    Steinberg, SM
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (03) : 968 - 975
12345678